Detalles de la búsqueda
1.
Bleeding control improves after switching to emicizumab: Real-world experience of 177 children in the PedNet registry.
Haemophilia
; 30(3): 685-692, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578720
2.
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel.
Haemophilia
; 30(2): 306-319, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38239180
3.
Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age.
Pediatr Blood Cancer
; 71(6): e30941, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462765
4.
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres.
Haemophilia
; 29(5): 1291-1298, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647211
5.
Long-term joint outcomes in adolescents with moderate or severe haemophilia A.
Haemophilia
; 28(6): 1054-1061, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35925557
6.
Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review.
Pediatr Hematol Oncol
; 39(5): 418-426, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35170384
7.
Characterization and treatment of congenital thrombotic thrombocytopenic purpura.
Blood
; 133(15): 1644-1651, 2019 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770395
8.
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.
Haemophilia
; 27(6): 932-937, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34403546
9.
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion.
Br J Haematol
; 191(5): 844-851, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32926422
10.
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
Haemophilia
; 26(3): 478-486, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32338433
11.
Emicizumab in previously untreated and minimally treated infants.
Haemophilia
; 28(2): e61-e63, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34981874
12.
Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence?
Haemophilia
; 28(2): e36-e38, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34821004
13.
Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects.
Haematologica
; 101(10): 1170-1179, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27479822
14.
Management and outcomes of paediatric patients on emicizumab prophylaxis undergoing surgical procedures: Experience from a large haemophilia centre in the UK.
Haemophilia
; 27(5): e620-e623, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34118116
15.
Mutation in GNE is associated with severe congenital thrombocytopenia.
Blood
; 132(17): 1855-1858, 2018 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29941673
16.
Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects.
Blood
; 122(25): 4090-3, 2013 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24100448
17.
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.
J Clin Oncol
; 42(8): 907-914, 2024 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37967307
18.
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.
J Clin Oncol
; 42(7): 821-831, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38033284
19.
Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.
Br J Haematol
; 181(5): 696-698, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28480955
20.
Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism.
Thromb Res
; 221: 92-96, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495716